Nonalcoholic Steatohepatitis Recruiting Phase 2 Trials for Elobixibat (DB12486)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04235205Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver DiseaseTreatment